VIYASHNSEViyash Scientific Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 17 Dec, 2025 · 18:41 IST

CA Hull gets 31.2% in Sequent via Viyash merger; no open offer needed

Listed Co AcquisitionNclt Scheme FiledStrategic Transactions View source PDFExplain this filing

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.6%Reaction day
₹210.18
prior close
₹210.25
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.3%-0.3% vs market
Pharmaceuticals peers, median of 152sector-0.4%-0.2% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.5
10m
-1.6
15m
-1.3
30m
-2.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.6-0.3-0.3-0.4-0.2
Next day
+0.1+0.9-0.8+0.6-0.5
2d
+4.0+2.3+1.7+1.0+3.0
3d
+3.3+2.4+0.9+1.1+2.2
4d
+1.8+1.8-0.0+0.9+0.8
5d
+1.4+1.3+0.1+0.5+0.9
1w
-1.5+0.4-2.0-0.2-1.3
15d
-5.5-1.1-4.4-0.3-5.3
1m
-2.2-3.3+1.1-2.7+0.5
2m
+6.3-0.5+6.8-2.4+8.7
3m
-7.2-8.2+1.0-9.0+1.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pursuant to NCLT-approved composite scheme (order Nov 18, 2025), Sequent Scientific allotted 13,61,60,231 shares (31.2% of capital) to CA Hull Investments at 56:100 exchange ratio. CA Harbor (existing promoter) stake fell from 52.33% to 30.20%. Combined promoter group now holds 61.4%. Transaction exempt from open offer under Regulation 10(1)(d)(ii) of SEBI Takeover Regulations.

Likely market impact

Viyash merged into Sequent at 56:100 ratio; promoter group now 61.4% combined; no open offer triggered; shareholding reshuffled.